Skaipher Nutraceutical Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 06-07-2024
- Paid Up Capital ₹ 3.00 M
as on 06-07-2024
- Company Age 9 Year, 14 Days
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 7.00 M
as on 06-07-2024
- Revenue 522.73%
(FY 2020)
- Profit 236.63%
(FY 2020)
- Ebitda 90.89%
(FY 2020)
- Net Worth 2.07%
(FY 2020)
- Total Assets 4.53%
(FY 2020)
About Skaipher Nutraceutical
The Corporate was formerly known as Skaipher Life Care India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹7.00 M.
Nookaraju Alladi, Parameshwar Bairi, Karamvir Phagna, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100WB2015PLC208673
- Company No.
208673
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Dec 2015
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skaipher Nutraceutical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Karamvir Phagna  | Director | Current | |
| Nookaraju Alladi | Director | 22-May-2017 | Current |
| Parameshwar Bairi | Director | 22-May-2017 | Current |
| Rajarshi Ghosh | Director | 22-Apr-2019 | Current |
Financial Performance of Skaipher Nutraceutical.
Skaipher Nutraceutical Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 522.73% increase. The company also saw a substantial improvement in profitability, with a 236.63% increase in profit. The company's net worth moved up by a moderate rise of 2.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skaipher Nutraceutical?
In 2020, Skaipher Nutraceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sameekrutha Housing Projects Private LimitedActive 2 years 10 months
Parameshwar Bairi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 21 Jun 2018 | ₹7.00 M | Open |
How Many Employees Work at Skaipher Nutraceutical?
Unlock and access historical data on people associated with Skaipher Nutraceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skaipher Nutraceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skaipher Nutraceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
